المؤلفون: Rossignol, Patrick, Fay, Renaud, Girerd, Nicolas, Zannad, Faiez

المساهمون: Centre d'investigation clinique plurithématique Pierre Drouin Nancy (CIC-P), Centre d'investigation clinique Nancy (CIC), Centre Hospitalier Régional Universitaire de Nancy (CHRU Nancy)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Lorraine (UL)-Centre Hospitalier Régional Universitaire de Nancy (CHRU Nancy)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Lorraine (UL), Défaillance Cardiovasculaire Aiguë et Chronique (DCAC), Centre Hospitalier Régional Universitaire de Nancy (CHRU Nancy)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Lorraine (UL), Cardiovascular and Renal Clinical Trialists Vandoeuvre-les-Nancy (INI-CRCT), Institut Lorrain du Coeur et des Vaisseaux Louis Mathieu Nancy, French-Clinical Research Infrastructure Network - F-CRIN Paris (Cardiovascular & Renal Clinical Trialists - CRCT ), PR, RF, NG, and FZ are supported by the RHU Fight‐HF, a public grant overseen by the French National Research Agency (ANR) as part of the second “Investissements d'Avenir” program (ANR‐15‐RHUS‐0004) and by the French PIA project “Lorraine Université d'Excellence” (ANR‐15‐IDEX‐04‐LUE), ANR-15-IDEX-0004,LUE,Isite LUE(2015), ANR-15-RHUS-0004,FIGHT-HF,Combattre l'insuffisance cardiaque(2015)

المصدر: EISSN: 2055-5822 ; ESC Heart Failure ; https://hal.univ-lorraine.fr/hal-02611159Test ; ESC Heart Failure, 2020, 7 (3), pp.1257-1263. ⟨10.1002/ehf2.12642⟩

مصطلحات موضوعية: Monitoring, Estimated plasma volume, Kidney function, Hypokalaemia, Hyperkalaemia, Heart failure with reduced ejection fraction, [SDV.MHEP.CSC]Life Sciences [q-bio]/Human health and pathology/Cardiology and cardiovascular system

العلاقة: info:eu-repo/semantics/altIdentifier/pmid/32274878; hal-02611159; https://hal.univ-lorraine.fr/hal-02611159Test; https://hal.univ-lorraine.fr/hal-02611159/documentTest; https://hal.univ-lorraine.fr/hal-02611159/file/ehf2.12642.pdfTest; PUBMED: 32274878; PUBMEDCENTRAL: PMC7261583

الإتاحة: https://doi.org/10.1002/ehf2.12642Test
https://hal.univ-lorraine.fr/hal-02611159Test
https://hal.univ-lorraine.fr/hal-02611159/documentTest
https://hal.univ-lorraine.fr/hal-02611159/file/ehf2.12642.pdfTest

المؤلفون: Rossignol, Patrick, Duarte, Kevin, Girerd, Nicolas, Karoui, Moez, McMurray, John J. V., Swedberg, Karl, van Veldhuisen, Dirk J., Pocock, Stuart, Dickstein, Kenneth, Zannad, Faiez, Pitt, Bertram

المصدر: Rossignol , P , Duarte , K , Girerd , N , Karoui , M , McMurray , J J V , Swedberg , K , van Veldhuisen , D J , Pocock , S , Dickstein , K , Zannad , F & Pitt , B 2020 , ' Cardiovascular risk associated with serum potassium in the context of mineralocorticoid receptor antagonist use in patients with heart failure and left ventricular dysfunction ' , European Journal of Heart Failure , vol. 22 , no. 8 , pp. 1402-1411 . https://doi.org/10.1002/ejhf.1724Test

مصطلحات موضوعية: Hyperkalaemia, Hypokalaemia, Heart failure with reduced ejection fraction, Mineralocorticoid receptor antagonist, Risk score, WORSENING RENAL-FUNCTION, AMBULATORY PATIENTS, SYSTEM INHIBITORS, HYPERKALEMIA, MORTALITY, SURVIVAL, EPLERENONE, PREDICTION, GUIDELINES, DIAGNOSIS

وصف الملف: application/pdf

العلاقة: https://research.rug.nl/en/publications/ca5e4437-b45c-4eb9-9310-794e87312722Test

الإتاحة: https://doi.org/10.1002/ejhf.1724Test
https://hdl.handle.net/11370/ca5e4437-b45c-4eb9-9310-794e87312722Test
https://research.rug.nl/en/publications/ca5e4437-b45c-4eb9-9310-794e87312722Test
https://pure.rug.nl/ws/files/119055079/Rossignol_et_al_2020_European_Journal_of_Heart_Failure.pdfTest